|
CN101880646A
|
|
Leachii mycoplasma Chinese isolate and isolation medium and application thereof
|
|
CN101880652A
|
|
Recombinant Newcastle disease attenuated vaccine strain for expressing pig interferon (alpha, beta or gamma
|
|
CN101870963A
|
|
Recombinant Newcastle disease virus attenuated vaccine strain for expressing dog interferon (alpha, beta or gamma)
|
|
CN101423821A
|
|
High-pathogenicity porcine reproductive and respiratory syndrome virus variation strain and use thereof
|
|
CN101376879A
|
|
Recombinant new castle disease LaSota attenuated vaccine strain expressing bovine interferon (alpha, beta and gamma-interferon)
|
|
CN101333248A
|
|
B cell antigen epitope polypeptide of encephalitis B virus E protein and uses thereof
|
|
CN101285056A
|
|
Hog cholera recombinant adenovirus and use thereof for preparing hog cholera genetic engineering bacterin
|
|
CN101285054A
|
|
ST cell lines for stably expressing T7 RNA polyase, constructing process and applications thereof
|
|
CN101451994A
|
|
Improved equine infectious anemia antigen production process
|
|
CN1970081A
|
|
Avian influenza virus marking vaccine and its production and application
|
|
CN101116749A
|
|
Swine fever replicon carrier vaccines, the method for preparing the same and application thereof
|
|
CN1884498A
|
|
Recombinant fowl influenza virus strain, its preparation method and the vaccine obtained therefrom
|
|
CN1730656A
|
|
DNA which code Mycoplasma mycoides subspecies N terminal lipoprotein
|
|
CN1546658A
|
|
Artificially recombinant H9N2 hypotype influenza virus and its uses
|
